Agios Pharmaceuticals (AGIO) Leases (2019 - 2025)
Agios Pharmaceuticals (AGIO) has disclosed Leases for 7 consecutive years, with $30.5 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases fell 28.98% year-over-year to $30.5 million, compared with a TTM value of $30.5 million through Dec 2025, down 28.98%, and an annual FY2025 reading of $30.5 million, down 28.98% over the prior year.
- Leases was $30.5 million for Q4 2025 at Agios Pharmaceuticals, down from $33.6 million in the prior quarter.
- Across five years, Leases topped out at $79.9 million in Q2 2021 and bottomed at $300000.0 in Q3 2021.
- Average Leases over 5 years is $48.8 million, with a median of $51.6 million recorded in 2024.
- The sharpest move saw Leases tumbled 99.65% in 2021, then surged 14379.68% in 2022.
- Year by year, Leases stood at $75.1 million in 2021, then dropped by 13.3% to $65.1 million in 2022, then fell by 16.46% to $54.4 million in 2023, then dropped by 21.19% to $42.9 million in 2024, then fell by 28.98% to $30.5 million in 2025.
- Business Quant data shows Leases for AGIO at $30.5 million in Q4 2025, $33.6 million in Q3 2025, and $36.8 million in Q2 2025.